Compare PHI & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHI | BLLN |
|---|---|---|
| Founded | 1928 | 2016 |
| Country | Philippines | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical Specialities |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.6B |
| IPO Year | 1995 | 2025 |
| Metric | PHI | BLLN |
|---|---|---|
| Price | $19.37 | $105.35 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $129.00 |
| AVG Volume (30 Days) | 213.4K | ★ 514.9K |
| Earning Date | 11-10-2026 | 11-04-2026 |
| Dividend Yield | ★ 5.43% | N/A |
| EPS Growth | N/A | ★ 103.40 |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $305,112,000.00 |
| Revenue This Year | $2.34 | $49.05 |
| Revenue Next Year | $2.25 | $26.16 |
| P/E Ratio | ★ $10.44 | $215.18 |
| Revenue Growth | N/A | ★ 99.97 |
| 52 Week Low | $16.71 | $61.96 |
| 52 Week High | $24.51 | $150.44 |
| Indicator | PHI | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 57.94 | 52.37 |
| Support Level | $19.19 | $89.26 |
| Resistance Level | $20.00 | $108.50 |
| Average True Range (ATR) | 0.55 | 6.23 |
| MACD | 0.20 | 0.24 |
| Stochastic Oscillator | 68.43 | 65.83 |
PLDT Inc is a telecommunications and digital services provider. The group has three reportable operating segments: Wireless, Fixed Line, and Others. Maximum revenue is generated from its Fixed Line segment, which offers fixed line telecommunications services, servicing retail, corporate, and small and medium-sized enterprises clients. The Fixed Line business segment offers data, voice, and miscellaneous services. It also offers secure data centers, multi-cloud, cybersecurity, data, and artificial intelligence (AI) solutions through different subsidiaries. The Wireless segment generates revenue by offering access to mobile internet via smartphones, mobile broadband using pocket WiFi, or home WiFi using fixed wireless broadband devices. Geographically, the group operates in the Philippines.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.